NCT01120249-D1
Dataset Information
Dataset ID: NCT01120249-D1
PubMed ID (PMID):
Publication Title:
Adjuvant Everolimus after Surgery for Renal-Cell Carcinoma (EVEREST): A Double-Blind, Placebo-Controlled, Randomised, Phase 3 Trial
Description of Dataset:
This dataset contains the results reported in The Lancet (Ryan et al., The Lancet, 2023). The clinical dataset contains patient-level data (one row per patient), including, eligibility, evaluability, treatment, demographic, baseline information, and unblinding. It also contains assessment data. NCT01120249-D2 contains toxicity data.
Data Dictionary:
Submission includes new data:
Yes
Trials Linked to Dataset
| NCT Trial Number | Disease Type |
|---|---|
| NCT01120249 |
Accessibility | Disclaimer | FOIA | HHS Vulnerability Disclosure | Privacy & Security
U.S. Department of Health and Human Services | National Institutes of Health | National Cancer Institute | USA.gov
NIH…Turning Discovery Into Health®